Allergy & Asthma Network to Advocate for Patients, Access to Care Innovations at Annual Capitol Hill Day on May 12 – PR Newswire (press release)

Allergy & Asthma Network to Advocate for Patients, Access to Care Innovations at Annual Capitol Hill Day on May 12
PR Newswire (press release)
VIENNA, Va., April 25, 2016 /PRNewswire-USNewswire/ — Allergy & Asthma Network will head to Capitol Hill on Thursday, May 12 to advocate for patients and urge Congress to take action on key legislative issues including telehealth services and school …
AAFA's asthma & allergy friendly(TM) Certification Program Celebrates 10 Successful YearsMarketwired (press release)

all 2 news articles »

View full post on asthma – Google News

FDA okays generic Singulair for asthma treatment – The Capitol Column


The Capitol Column

FDA okays generic Singulair for asthma treatment
The Capitol Column
The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesRTT News
FDA OKs generic SingulairChicago Tribune
Generic Singulair ApprovedWebMD
Globes –MedPage Today
all 37 news articles »

View full post on asthma – Google News